N@N

HST Global Quarterly Update

^{Published on 2008-11-25 08:00:59 - Market Wire}
 

HAMPTON, Va.--([ BUSINESS WIRE ])--HST Global, Inc. (OTCBB: HSTC), an integrated biotechnology and wellness company, today announced plans for the first quarter fiscal 2009.

The growing acceptance of alternative cancer treatments worldwide has placed HST Global in perfect position to launch a wholly owned division dedicated to opening our own brand of Cancer Treatment Centers. While we continue to look for in-licensing pre-clinical drug candidates, this strategy will enable the company to address the challenges individuals face in the treatment of cancer in the later stages.

Ronald Howell, President and CEO of HST Global, Inc. stated "There is a growing population of individuals experiencing the lack of available alternatives in treating late stage cancer. We have been working with a number of highly visible Physicians that are and have developed successful protocols that are meeting with success in the treatment of this population. As such, we will begin opening a privately branded chain of Cancer Treatment Centers strategically positioned around the world through a new wholly owned subsidiary."

Mr. Howell went on to say, "The distribution channel established through our Cancer Treatment Centers will serve as a platform for implementing existing technologies and serve to identify appropriate communities for treatment with new and emerging drug candidates as they become available."

Cancer is an epidemic that is worldwide and one that does not discriminate. HST Global, Inc. has been involved with pre-clinical and proven drug candidates that have shown high efficacy in the treatment of various cancers. The success and high efficacy achieved in these treatments has given the company a position of visibility that has attracted a number of International partners that want to move forward and open Centers worldwide. Movement to establish a global chain of Cancer Treatment Centers will provide an immediate revenue stream to the company.

Given the current negotiations HST believes:

• The Company will open its first corporate owned center in the first quarter 2009.
• The Company will open five partner centers worldwide in fiscal 2009.
• The annual estimated revenue stream from each individual clinic is projected to be between 8 - 10 million dollars per year.
• The Company will continue to seek out revolutionary and innovative products for the treatment of cancer and other life threatening diseases.

Due to the unfortunate nature of cancer, the Company is not as affected by current and/or future economic conditions. The Company's intention is to provide World-Class treatment of this and other life threatening diseases.

About HST Global, Inc.

HST Global, Inc. is a development stage biotechnology company that acquires and develops innovative products for the treatment of cancer and other life threatening illnesses. We focus on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer, then developing those drug candidates for commercial use and developing a network of Wellness Centers Worldwide.